AfoliOpen Afoli →

Sevelamer

Sevelamer is an active ingredient of the class «antihyperkalemic agents».

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

Renvela ® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.

US label

Sevelamer carbonate Winthrop is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.

EMA

How it works

Class: antihyperkalemic agents

Common side effects

In long-term studies with sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, the most common adverse events included: vomiting (22%), nausea (20%), diarrhea (19%), dyspepsia (16%), abdominal pain (9%), flatulence (8%), and constipation (8%).

US label

Who should not take it

Renvela is contraindicated in patients with bowel obstruction. Renvela is contraindicated in patients with known hypersensitivity to sevelamer carbonate, sevelamer hydrochloride, or to any of the excipients.

US label

Pregnancy and breastfeeding

Sevelamer carbonate is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Renvela

European Union

Renagel · Renvela · Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva)

Canada

Accel-Sevelamer · Renvela

Other trade names

Sevelamer carbonate zentiva

Approval status

US Food and Drug Administration
prescription · since 2007
European Medicines Agency
authorised · since 2000
Health Canada
prescription · marketed
First approval anywhere
2007

Codes

ATC
V03AE02
RxNorm CUI
214824
ChEMBL
CHEMBL5314349
PubChem CID
3085017
Wikidata
Q904153

Frequently asked questions

What is Sevelamer used for?

Sevelamer is used for: Hyperphosphatemia, Phosphorus metabolism disease, Chronic renal insufficiency, and Renal dialysis.

What kind of medicine is Sevelamer?

Sevelamer is an active ingredient of the class «antihyperkalemic agents».

What are the brand names of Sevelamer?

Brand names of Sevelamer include Renvela, Renagel, Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva), Accel-Sevelamer, and Sevelamer carbonate zentiva.

Sources and licences

Updated November 15, 2026